KD Treatment for Super-refractory Status Epilepticus

Key facts

Sponsor

Xuanwu Hospital, Beijing

Intervention

the ketogenic diet(other)

Enrollment

84 enrolled

Eligibility

14-80 years · All sexes

Timeline

2025 – 2027

Study locations (15)

• The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
• Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, Beijing Municipality, China
• Fujian Medical University Union Hospital, Fuzhou, Fujian, China
• The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
• Guizhou Provincial People's Hospital, Guiyang, Guizhou, China
• The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China
• The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
• The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
• The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
• Chifeng Municipal Hospital, Chifeng, Neimenggu, China
• Qilu Hospital，Shandong University, Jinan, Shandong, China
• The Second Affiliated Hospital of Zhejiang University School of Medicine, Hanzhou, Zhejiang, China
• Beijing Tongren Hospital, Capital Medical University, Beijing, China
• The First Hospital of Jilin University, Jilin, China
• Liaocheng People's Hospital, Liaocheng, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.